1-(4-phenoxyphenyl)-2-(triphenyl-λ⁵-phosphaneylidene)ethan-1-one | 40612-93-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-phenoxyphenyl)-2-(triphenyl-λ⁵-phosphaneylidene)ethan-1-one
• 英文别名: 1-(4-Phenoxyphenyl)-2-(triphenyl-lambda5-phosphanylidene)ethanone；1-(4-phenoxyphenyl)-2-(triphenyl-λ5-phosphanylidene)ethanone
• CAS: 40612-93-9
• 化学式: C₃₂H₂₅O₂P
• 分子量: 472.523
• InChiKey: BALNKJVMHMVCSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  35
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER<br/>[FR] DÉRIVÉS DE PYRROLOIMIDAZOLE OU ANALOGUES DE CEUX-CI UTILES, ENTRE AUTRES, DANS LE TRAITEMENT DU CANCER
  申请人：EMCURE PHARMACEUTICALS LTD

  公开号：WO2017134555A1

  公开（公告）日：2017-08-10

  Present invention relates to novel heterocyclic compounds as indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) modulators. Compounds of the present invention inhibit tryptophan degradation by modulating IDO and/or TDO. Formula (I) The invention further relates to the process of their preparation, pharmaceutical composition and their use in modulating the activity of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3- dioxygenase (TDO). The compounds of the invention can be used alone or in combination for the treatment of conditions that benefits from the inhibition of tryptophan degradation.

  本发明涉及作为吲哚胺2,3-二氧化酶（IDO）和/或色氨酸2,3-二氧化酶（TDO）调节剂的新型杂环化合物。本发明的化合物通过调节IDO和/或TDO来抑制色氨酸降解。公式（I）。本发明还涉及它们的制备过程、药物组合物及其在调节吲哚胺2,3-二氧化酶（IDO）和/或色氨酸2,3-二氧化酶（TDO）活性中的应用。本发明的化合物可以单独使用或与其他药物组合用于治疗受益于抑制色氨酸降解的疾病。
• DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER
  申请人：EMCURE PHARMACEUTICALS LIMITED

  公开号：US20190031665A1

  公开（公告）日：2019-01-31

  Present invention relates to novel heterocyclic compounds as indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) modulators. Compounds of the present invention inhibit tryptophan degradation by modulating IDO and/or TDO. The invention further relates to the process of their preparation, pharmaceutical composition and their use in modulating the activity of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO). The compounds of the invention can be used alone or in combination for the treatment of conditions that benefits from the inhibition of tryptophan degradation.